Listed by the USPTO as MANNAN, MIKAIL A
Tech Center 3700 • Art Units: 3731 3734 3771 3774 3776
This examiner grants 68% of resolved cases
MANNAN, MIKAIL A is assigned to tech center 3700 and art unit 3731. The profile covers 319 resolved cases, a 68.3% allowance rate, and a median of 1252 days to allowance. The 24.0% interview lift indicates that interviews are associated with improved allowance outcomes in the recorded cases.
The recurring companies are Edwards Lifesciences Corporation, Boston Scientific Corporation, and Bard Peripheral Vascular Inc. The listed firms are SEAGER, TUFTE & WICKHEM, LLP, The Dobrusin Law Firm P.C., and COOLEY LLP. The median time to allowance makes schedule management relevant for applicants in this art unit.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18626986 | DEVICE AND METHOD FOR TREATING TISSUE USING A PATCH | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18461284 | MEDICAL DEVICE INCLUDING ATTACHABLE COMPONENTS | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 18108112 | SHEATH WITH COLLAPSIBLE CAPSULE | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18099013 | HEART VALVE PREP ASSIST PACKAGING | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 17515228 | TISSUE EXPANSION DEVICE | Non-Final OA | Allergan, Inc. |
| 18103361 | EXPANDABLE SHEATH FOR INTRODUCING AN ENDOVASCULAR DELIVERY DEVICE INTO A BODY | Non-Final OA | Edwards Lifesciences Corporation |
| 17960480 | PROSTHETIC HEART VALVE DELIVERY APPARATUS | Final Rejection | Edwards Lifesciences Corporation |
| 17956729 | LOW TEMPERATURE HYDROPHILIC ADHESIVE FOR USE IN EXPANDABLE SHEATH FOR INTRODUCING AN ENDOVASCULAR DELIVERY DEVICE INTO A BODY | Final Rejection | Edwards Lifesciences Corporation |
| 17940868 | DELIVERY SYSTEM CONFIGURATIONS | Final Rejection | Edwards Lifesciences Corporation |
| 17895945 | EXPANDABLE SHEATH WITH EXTRUDED SEGMENTS | Non-Final OA | Edwards Lifesciences Corporation |
| 17190514 | INTRAOCULAR IMPLANT AND METHOD FOR PRODUCING AN INTRAOCULAR IMPLANT | Final Rejection | Carl Zeiss Meditec AG |
| 18043526 | ACCESS SHEATH FOR PROSTHETIC CARDIAC VALVE DELIVERY SYSTEMS | Final Rejection | SHIFAMED HOLDINGS, LLC |
| 18245046 | CLOSURE DEVICES, VASCULAR REPAIR ASSEMBLIES, AND METHODS FOR REPAIRING VEIN VALVE INSUFFICIENCY | Non-Final OA | Bard Peripheral Vascular, Inc. |
| 18019772 | Systems and Methods for Endovascularly Restoring Venous Valve Function | Non-Final OA | Bard Peripheral Vascular, Inc. |
| 17832420 | KNOTLESS SUTURE ANCHOR | Final Rejection | In2Bones USA, LLC |
| 18170748 | HEART VALVE REPAIR | Non-Final OA | Medtronic Vascular, Inc. |
| 18678856 | DELIVERY SYSTEM FOR HEART VALVE REPLACEMENT | Non-Final OA | Cephea Valve Technologies, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy68.3% of resolved applications examined by Mikail A Mannan were allowed (319 resolved cases), compared with 63.1% across Art Unit 3731 over the last five years.
This examiner's interview lift is +24.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Mikail A Mannan took 1,252 days on average from filing to allowance.
Mikail A Mannan examines applications in Art Unit 3731 in Tech Center 3700 (Medical Devices & Mechanical Engineering).